Hosted on MSN10mon
Cipla, Glenmark recall drugs in US due to manufacturing issues
Drug makers Cipla and Glenmark are recalling their products from the US market due to manufacturing issues. In accordance with the latest Enforcement Report from the US Food and Drug ...
Hosted on MSN1mon
Jefferies raises Cipla stock price target to INR1,580
On Tuesday, Jefferies analyst Alok Dalal increased the price target for Cipla (NSE:CIPL) Ltd. (CIPLA:IN) shares to INR1,580, up from INR1,560, while maintaining a Hold rating on the stock.
Medindia1y
Cipla launches 3-in-1 AIDS drug in India
Cipla has launched an innovative combination of 3 HIV/AIDS drugs, Viraday that needs to be taken just once a day for effective treatment. Cipla has launched an innovative combination of 3 HIV/AIDS ...